Clinical trial
Titration Patterns, Patient Characteristics and Hypotension Events Among Patients Initiating Vericiguat in Real World Settings in the United States (US)
NCT06363110 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Titration Patterns, Patient Characteristics and Hypotension Events Among Patients Initiating Vericiguat in Real World Settings in the United States (US)
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 10, 2024
- Completion date
- June 24, 2024
- Enrollment
- 1,400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic heart failure with reduced ejection fraction